Know Cancer

or
forgot password

Prospective Controlled Study Evaluating Cryocontact Therapy of Infantile Hemangiomas of Preterm Infants


N/A
N/A
11 Weeks
Not Enrolling
Both
Hemangioma of Preterm Infants

Thank you

Trial Information

Prospective Controlled Study Evaluating Cryocontact Therapy of Infantile Hemangiomas of Preterm Infants


Inclusion Criteria:



- preterm infants <=34 weeks GA with hemangioma

Exclusion Criteria:

- no hemangioma

Type of Study:

Interventional

Study Design:

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Outcome Measure:

Hemangioma outcome

Outcome Description:

skin status

Outcome Time Frame:

1 year

Safety Issue:

Yes

Principal Investigator

Rangmar Goelz, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University Hospital

Authority:

Germany: Ethics Commission

Study ID:

CryoHaem

NCT ID:

NCT01059045

Start Date:

August 2004

Completion Date:

December 2009

Related Keywords:

  • Hemangioma of Preterm Infants
  • Hemangioma
  • Hemangioma, Capillary

Name

Location